Please provide your email address to receive an email when new articles are posted on . The FDA has approved the Tecnis Symfony IOL for the treatment of cataracts, Abbott announced in a press release.

Traditional monofocal IOLs have been limited to improving distance vision. The Tecnis Symfony IOL improves visual acuity at close, intermediate and far ranges and, therefore, may reduce the need for ...

ABBOTT PARK, Ill., June 24, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Marking (Conformite Europeenne) in Europe for the TECNIS ® Symfony Extended Range of Vision ...

The Tecnis Symfony IOL is the first intraocular lens able to allow cataract patients to have extended depth-of-focus, according to FDA. Chris Newmarker FDA recently announced approval of an ...

IRVINE, Calif., Sept. 28, 2022 /PRNewswire/ -- Johnson & Johnson Vision,** a global leader in eye health and part of Johnson & Johnson MedTech,*** today announced availability of our ...

Abbott announced that the Food and Drug Administration (FDA) has approved the Tecnis Symfony Intraocular Lenses for the treatment of cataracts. Abbott announced that the Food and Drug Administration ...

Abbott has earned FDA approval for its Tecnis Symfony Intraocular Lenses for the treatment of cataracts. The approval includes the Tecnis Symfony Toric IOL, a version of the lenses that are made for ...

Please provide your email address to receive an email when new articles are posted on . With advancing technology, cataract surgery is now less invasive, resulting in better recovery and outcomes. Not ...

Abbott announced that its pivotal clinical trial of Tecnis Symfony 1-Piece Acrylic Intraocular Lens (IOL) met its primary endpoint of improved intermediate vision. Data from this study showed that ...